BRIEF published on 03/04/2024 at 15:51, 8 months 20 days ago Vanguard Group's Increased Stake in Barratt Developments Plc Takeover Code Vanguard Group Share Acquisition Barratt Developments Financial Stake
PRESS RELEASE published on 03/04/2024 at 15:46, 8 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses a 4.87% stake in Barratt Developments plc as of 01 March 2024, with recent purchase and sale of 10p ordinary shares Financial Transactions The Vanguard Group, Inc. Stake Disclosure Barratt Developments Plc 10p Ordinary Shares
BRIEF published on 02/29/2024 at 16:28, 8 months 24 days ago The Vanguard Group Reports Increased Stake in Barratt Developments plc Real Estate Investment The Vanguard Group Financial Disclosure Barratt Developments Plc Stock Acquisition
PRESS RELEASE published on 02/29/2024 at 16:23, 8 months 24 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. files Form 8.3 disclosing 4.87% ownership in Barratt Developments plc, with purchases made at 4.64 GBP per unit Form 8.3 The Vanguard Group Inc. Ownership Disclosure Barratt Developments Plc Stock Purchases
BRIEF published on 02/28/2024 at 15:29, 8 months 25 days ago The Vanguard Group, Inc. announces investment in Barratt Developments plc Vanguard Group Participation Barratt Developments Ordinary Actions Estate Market
PRESS RELEASE published on 02/28/2024 at 15:29, 8 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses a 4.87% stake in Barratt Developments plc. Dealings include purchasing 34,710 securities at 4.70 GBP/unit The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Barratt Developments Plc
BRIEF published on 02/27/2024 at 15:24, 8 months 26 days ago Vanguard Group's increased stake in Barratt Developments plc Form 8.3 Vanguard Group Stock Market Participation Barratt Developments Plc
PRESS RELEASE published on 02/27/2024 at 15:24, 8 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses a 4.86% interest in Barratt Developments plc. Details of securities holdings and recent dealings included Securities Disclosure The Vanguard Group Inc Barratt Developments Plc Stock Transactions Financial Interest
BRIEF published on 02/26/2024 at 14:45, 8 months 27 days ago Vanguard Group increases its position in Barratt Developments plc Investment Takeover Code Vanguard Group Real Estate Sector Barratt Developments Plc
PRESS RELEASE published on 02/26/2024 at 14:45, 8 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses public opening position in Barratt Developments plc according to Form 8.3 on 26 Feb 2024 Financial News Form 8.3 Position Disclosure Vanguard Group Inc. Barratt Developments Plc
Published on 11/22/2024 at 23:55, 1 day 18 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 18 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 19 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 19 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 23 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 16:55, 2 days 1 hour ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 3 days 11 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 22 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024